Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma

Saved in:

Bibliographic Details
Main Authors:	Raphaella Lambert, BA, Scott Stratman, MD, Grace Rabinowitz, BA, Hannah Verma, BA, Jonas A. Adalsteinsson, MD, PhD, George Niedt, MD, Benjamin Ungar, MD, Nicholas Gulati, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	JAAD Case Reports
Subjects:	cutaneous immune-related adverse event eczema hepatocellular carcinoma immune checkpoint inhibitor tremelimumab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512625000116
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet